Skip to content

Clinical trials

Phase 1 Digestive System Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 1 Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20211
20223
20235
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Unknown status3
Completed1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Baili Pharmaceutical Co., Ltd.7
Sir Run Run Shaw Hospital3
Beijing Immunochina Medical Science & Technology Co., Ltd.1
BioSyngen Pte Ltd1
Dongfang Hospital Beijing University of Chinese Medicine1
Peking University1
Ruijin Hospital1
Shanghai Juncell Therapeutics1
Taizhou HoudeAoke Biomedical Co., Ltd.1
Zhejiang Doer Biologics Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms18
Colonic Neoplasms1
Colorectal Neoplasms1
Esophageal Neoplasms1
Pancreatic Neoplasms1
Stomach Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.